Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (NCT07212452) titled 'Tranexamic Acid : Nebulization vs IV Route for Hemoptysis' on Sept. 30.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: University of Health Sciences Lahore
Condition:
Hemoptysis
NEBULIZATION
Tranexamic Acid
Intervention:
Drug: Tranexamic Acid (TXA)
Recruitment Status: Recruiting
Phase: Phase 2/Phase 3
Date of First Enrollment: August 1, 2025
Target Sample Size: 172
Countries of Recruitment:
Pakistan
To know more, visit https://clinicaltrials.gov/study/NCT07212452
Publish...